Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Publicis Groupe announces acquisition of In-Sync

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Sutter Health and Allina Health Sign...

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to...

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

Publicis Groupe announced that it has acquired Toronto-based In-Sync, a recognized thought leader in the customer insight space. In-Sync will become part of Publicis Healthcare Communications Group (PHCG). In-Sync, with 75 employees, is a market research consultancy offering a fully integrated suite of innovative, quantitative and qualitative branded products to top biopharma companies worldwide. The acquisition of In-Sync will strengthen PHCG’s edge by providing clients with greater customer insight in the healthcare space.

In-Sync will maintain its current location and name and will continue to be led by founding partner and President Janet Winkler. The agency will report to Sam Welch, COO of PHCG North America.

Winkler formed In-Sync in 1989, later focusing on the health and wellness space, which is the core focus of its business today. The agency brings together the disciplines of market research, brand strategy, and management consulting with the social studies of human groups and individuals, utilizing its proprietary 360 Degree Insight Engine(TM). Their impressive and growing client list includes many of the top pharma companies.

Nick Colucci, President and CEO of PHCG, said: "Our heathcare network is strong and growing in part by finding value-creating acquisitions such as In-Sync, which bring tremendous strategy and innovative solutions to our biopharma clients and their brands." Colucci continued, "The In-Sync team is already an impressive and highly sought after company, but we believe they will grow exponentially once they become part of our global network."

Winkler said, "Joining PHCG enables us to extend our global presence and expand client value through the Group’s full scope of talent, resources and service." She continued, "We look forward to delivering continued outstanding work to our current clients. We are also excited by the opportunity to more seamlessly integrate customer insight and branding with the ultimate goal of helping our clients better deliver against the needs of their customers."

Welch said, "For clients looking to establish new brands or accelerate the growth of an existing one, In-Sync not only is a tremendous asset in itself, but also builds on the incredible foundation existing in our current strategic agencies. Leveraged on a global scale, we believe that In-Sync’s capabilities not only are transformative to the healthcare industry, they align with the future direction of PHCG."

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Sutter Health and Allina Health Sign Definitive Agreement to Join Forces

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to Build the Largest Pan-Asian Healthcare Investment Platform

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป